PB1-F2 Amino Acids Regulate Influenza A Viral Polymerase Activity


 Influenza A virus, PB1-F2, polymerase activity, minigenome system.

How to Cite

Yumi Ueda, Motoko Tanaka, Yukihiro Kyan, Mitsutaka Yoshida, Kenji Sasahara, & Kyoko Shinya. (2014). PB1-F2 Amino Acids Regulate Influenza A Viral Polymerase Activity. Journal of Basic & Applied Sciences, 10, 1–6. https://doi.org/10.6000/1927-5129.2014.10.01


In 2001, the 11th influenza A viral protein PB1-F2 was detected and found to be encoded by an alternative open reading frame in the PB1 polymerase gene. PB1-F2 has several unique functions, including roles in promoting apoptosis, increasing inflammation, and regulating viral polymerase activity. This study focused on a single PB1-F2 function: regulation of polymerase activity. We constructed a minigenome system to determine the influence of PB1-F2 amino acid (aa) mutations on polymerase activity. We examined four types of aa mutations: three species-specific aa mutations and one mutation that alters pathogenicity in mice. We discovered that an arginine (R) residue at aa position 29 is highly conserved in avian-derived virus strains. Introducing this mutation into mammalian strain A/WSN/33 (H1N1) led to a marked increase in polymerase activity in mammalian cells.These findings suggest that as PB1-F2 in H5N1 viruses regulates viral polymerase activity, it could be targeted for control of avian influenza infection and drug discovery.



Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992; 56: 152-79.

Tanaka M, Tsumura K, Ito H, et al. Characteristics of influenza virus genome mutations. Kobe J 2011; 57: 116-27.

Chen W, Calvo PA, Malide D, et al. A Novel Influenza A virus mitochondrial protein that induces cell death. Nat Med 2001; 7: 1306-12. http://dx.doi.org/10.1038/nm1201-1306

Zell R, Krumbholz A, Wutzler P. Influenza A virus PB1-F2 gene. Emerg Infect Dis 2006; 12: 1607-8; author reply 1608-9. http://dx.doi.org/10.3201/eid1210.060511

Yamada H, Chounan R, Higashi Y, Kurihara N, Kido H. Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria. FEBS Lett 2004; 578: 331-6. http://dx.doi.org/10.1016/j.febslet.2004.11.017

Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 2005; 1: e4. http://dx.doi.org/10.1371/journal.pone.0057894

Mitzner D, Dudek SE, Studtrucker N, et al. Phosphorylation of the influenza A virus protein PB1-F2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell Microbiol 2009; 11: 1502-16. http://dx.doi.org/10.1111/j.1462-5822.2009.01343.x

Leymarie O, Jouvion G, Herve PL, et al. Kinetic characterization of PB1-F2-mediated immunopathology during highly pathogenic avian H5N1 influenza virus infection. PLoS One 2013; 8: e57894.

Dudek SE, Wixler L, Nordhoff C, et al. The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol Chem 2011; 392: 1135-44. http://dx.doi.org/10.1515/BC.2011.174

Ozawa M, Basnet S, Burley LM, et al. Impact of amino acid mutations in PB2, PB1-F2, and NS1 on the replication and pathogenicity of pandemic (H1N1) 2009 influenza viruses. J Virol 2011; 85: 4596-601. http://dx.doi.org/10.1128/JVI.00029-11

Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, Ludwig S. The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol2008; 10: 1140-52. http://dx.doi.org/10.1111/j.1462-5822.2008.01116.x

McAuley JL, Zhang K, McCullers JA. The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol 2010; 84: 558-64. http://dx.doi.org/10.1128/JVI.01785-09

Chen CJ, Chen GW, Wang CH, Huang CH, Wang YC, Shih SR. Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J Virol 2010; 84: 10051-62. http://dx.doi.org/10.1128/JVI.00592-10

Pena L, Vincent AL, Loving CL, et al. Restored PB1-F2 in the 2009 Pandemic H1N1 influenza virus has minimal effects in swine. J Virol 2012; 86: 5523-32. http://dx.doi.org/10.1128/JVI.00134-12

Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193-9. http://dx.doi.org/10.1016/0378-1119(91)90434-D

Ozawa M, Fujii K, Muramoto Y, et al. Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol 2007; 81: 30-41. http://dx.doi.org/10.1128/JVI.01434-06

Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. A Single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog2007; 3: 1414-21. http://dx.doi.org/10.1371/journal.ppat.0030141

Conenello GM, Tisoncik JR, Rosenzweig E, Varga ZT, Palese P, Katze MG. A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response In vivo. J Virol 2011; 85: 652-62. http://dx.doi.org/10.1128/JVI.01987-10

Bruns K, Studtrucker N, Sharma A, et al. Structural characterization and oligomerization of PB1-F2, a proapoptotic influenza A virus protein. J Biol Chem 2007; 282: 353-63. http://dx.doi.org/10.1074/jbc.M606494200

Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW. The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol 2003; 77: 7214-24. http://dx.doi.org/10.1128/JVI.77.13.7214-7224.2003

Schmolke M, Manicassamy B, Pena L, et al. Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species. PLoS Pathog 2011; 7: e1002186. http://dx.doi.org/10.1371/journal.ppat.1002186

Kiso M, Takahashi K, Sakai-Tagawa Y, et al. T-705 (Favipiravir) Activity against lethal H5N1 influenza A viruses. Proc Natl Acad Sci USA 2010; 107: 882-7. http://dx.doi.org/10.1073/pnas.0909603107

Sleeman K, Mishin VP, Deyde VM, Furuta Y, Klimov AI, Gubareva LV. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses. Antimicrob Agents Chemother 2010; 54: 2517-24. http://dx.doi.org/10.1128/AAC.01739-09

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2014 Yumi Ueda, Motoko Tanaka, Yukihiro Kyan, Mitsutaka Yoshida, Kenji Sasahara, Kyoko Shinya